160 related articles for article (PubMed ID: 15827336)
1. p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome.
Nakase M; Inui M; Okumura K; Kamei T; Nakamura S; Tagawa T
Mol Cancer Ther; 2005 Apr; 4(4):625-31. PubMed ID: 15827336
[TBL] [Abstract][Full Text] [Related]
2. p53 gene therapy of human breast carcinoma: using a transferrin-modified silica nanoparticles.
Rejeeth C; Kannan S
Breast Cancer; 2016 Jan; 23(1):101-110. PubMed ID: 24795076
[TBL] [Abstract][Full Text] [Related]
3. Bax gene therapy for human osteosarcoma using cationic liposomes in vivo.
Okumura K; Nakase M; Nakamura S; Kamei T; Inui M; Tagawa T
Oncol Rep; 2007 Apr; 17(4):769-73. PubMed ID: 17342313
[TBL] [Abstract][Full Text] [Related]
4. p53 and PTEN/MMAC1/TEP1 gene therapy of human prostate PC-3 carcinoma xenograft, using transferrin-facilitated lipofection gene delivery strategy.
Seki M; Iwakawa J; Cheng H; Cheng PW
Hum Gene Ther; 2002 Apr; 13(6):761-73. PubMed ID: 11936974
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of bax, bcl-2, and p53 staining in primary osteosarcoma.
Kaseta MK; Khaldi L; Gomatos IP; Tzagarakis GP; Alevizos L; Leandros E; Papagelopoulos PJ; Soucacos PN
J Surg Oncol; 2008 Mar; 97(3):259-66. PubMed ID: 18161867
[TBL] [Abstract][Full Text] [Related]
6. Transferrin-liposome-mediated p53 sensitization of squamous cell carcinoma of the head and neck to radiation in vitro.
Xu L; Pirollo KF; Chang EH
Hum Gene Ther; 1997 Mar; 8(4):467-75. PubMed ID: 9054521
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated ING4 Gene Transfer in Osteosarcoma Suppresses Tumor Growth via Induction of Apoptosis and Inhibition of Tumor Angiogenesis.
Xu M; Xie Y; Sheng W; Miao J; Yang J
Technol Cancer Res Treat; 2015 Oct; 14(5):617-26. PubMed ID: 24750000
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor effect of adenoviral vector-mediated p53 gene transfer on the growth of canine osteosarcoma xenografts in nude mice.
Kanaya N; Yazawa M; Goto-Koshino Y; Mochizuki M; Nishimura R; Ohno K; Sasaki N; Tsujimoto H
J Vet Med Sci; 2011 Jul; 73(7):877-83. PubMed ID: 21350316
[TBL] [Abstract][Full Text] [Related]
9. Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer.
Zou Y; Zong G; Ling YH; Perez-Soler R
Cancer Gene Ther; 2000 May; 7(5):683-96. PubMed ID: 10830716
[TBL] [Abstract][Full Text] [Related]
10. Triazine-modified dendrimer for efficient TRAIL gene therapy in osteosarcoma.
Wang Y; Li L; Shao N; Hu Z; Chen H; Xu L; Wang C; Cheng Y; Xiao J
Acta Biomater; 2015 Apr; 17():115-24. PubMed ID: 25595474
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of cationic liposome-mediated Bax gene transfer in osteosarcoma cells: induction of apoptosis and caspase-independent cell death.
Okumura K; Nakase M; Nakamura S; Inui M; Hiramoto K; Tagawa T
Int J Oncol; 2005 Aug; 27(2):433-8. PubMed ID: 16010425
[TBL] [Abstract][Full Text] [Related]
12. Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes.
Xu L; Huang CC; Huang W; Tang WH; Rait A; Yin YZ; Cruz I; Xiang LM; Pirollo KF; Chang EH
Mol Cancer Ther; 2002 Mar; 1(5):337-46. PubMed ID: 12489850
[TBL] [Abstract][Full Text] [Related]
13. Cancer gene therapy mediated by CTS1, a p53 derivative: advantage over wild-type p53 in growth inhibition of human tumors overexpressing MDM2.
Bougeret C; Virone-Oddos A; Adeline E; Lacroix F; Lefranc C; Ferrero L; Huet T
Cancer Gene Ther; 2000 May; 7(5):789-98. PubMed ID: 10830726
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of bax and p53 naked gene transfer in lung cancer: in vitro and in vivo analysis.
Coll JL; Negoescu A; Louis N; Sachs L; Tenaud C; Girardot V; Demeinex B; Brambilla E; Brambilla C; Favrot M
Hum Gene Ther; 1998 Sep; 9(14):2063-74. PubMed ID: 9759933
[TBL] [Abstract][Full Text] [Related]
15. Additive effect of adenovirus-mediated E2F-1 gene transfer and topoisomerase II inhibitors on apoptosis in human osteosarcoma cells.
Yang HL; Dong YB; Elliott MJ; Wong SL; McMasters KM
Cancer Gene Ther; 2001 Apr; 8(4):241-51. PubMed ID: 11393276
[TBL] [Abstract][Full Text] [Related]
16. Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI-p53 complexes.
Densmore CL; Kleinerman ES; Gautam A; Jia SF; Xu B; Worth LL; Waldrep JC; Fung YK; T'Ang A; Knight V
Cancer Gene Ther; 2001 Sep; 8(9):619-27. PubMed ID: 11593330
[TBL] [Abstract][Full Text] [Related]
17. Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts.
Xu L; Pirollo KF; Tang WH; Rait A; Chang EH
Hum Gene Ther; 1999 Dec; 10(18):2941-52. PubMed ID: 10609655
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the human mandibular osteoblastic osteosarcoma cell line HOSM-2 after long-term culture.
Narita M; Nomura J; Nakase M; Inui M; Murata T; Hamaguchi Y; Tagawa T
Oral Oncol; 2004 Aug; 40(7):742-50. PubMed ID: 15172645
[TBL] [Abstract][Full Text] [Related]
19. Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv.
Xu L; Tang WH; Huang CC; Alexander W; Xiang LM; Pirollo KF; Rait A; Chang EH
Mol Med; 2001 Oct; 7(10):723-34. PubMed ID: 11713371
[TBL] [Abstract][Full Text] [Related]
20. Construction of an EGF receptor-mediated histone H1(0)-based gene delivery system.
Dai FH; Chen Y; Ren CC; Li JJ; Yao M; Han JS; Gong Y; Yang SL; Zhu JD; Gu JR
J Cancer Res Clin Oncol; 2003 Aug; 129(8):456-62. PubMed ID: 12884022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
